DRYNOL 20 MG TABLETS
1. What DRYNOL is and what it is used for
2. What you need to know before you take DRYNOL
3. How to take DRYNOL
4. Possible side effects
5. How to store DRYNOL
6. Contents of the pack and other information
DRYNOL contains the active substance bilastine which is an antihistamine. DRYNOL is used to relieve the symptoms of hayfever (sneezing, itchy, runny, blocked-up nose and red and watery eyes) and other forms of allergic rhinitis. It may also be used to treat itchy skin rashes (hives or urticaria).
if you are allergic to bilastine or any of the other ingredients of this medicine (listed in section 6).
Talk to your doctor or pharmacist before using Drynol if you have moderate or severe renal impairment and in addition you are taking other medicines (see ”Other medicines and Drynol”).
Do not give this medicine to children under 12 years of age
Do not exceed the recommended dose. If symptoms persist, consult your doctor.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription.
In particular, please discuss with your doctor if you are taking any of the following medicines:
These tablets should not be taken with food or with grapefruit juice or other fruit juices, as this will decrease the effect of bilastine. To avoid this, you can:
Bilastine, at the recommended dose (20 mg), does not increase the drowsiness produced by alcohol.
There are no or limited amount of data from the use of bilastine in pregnant women and during breast-feeding and on the effects on fertility.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask you doctor for advice before taking this medicine. Ask your doctor or pharmacist for advice before taking any medicine.
A study performed to establish the effect of bilastine on the ability to drive demonstrated that treatment with 20 mg bilastine does not affect the driving performance. However very rarely some people experience drowsiness, which may affect their ability to drive or use machines.
Always take this medicine exactly as your doctor or pharmacist have told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose in adults, including the elderly and adolescents aged 12 years and over, is 1 tablet (20 mg) a day.
Regarding the duration of treatment, your physician will determine the type of disease you are suffering from and will determine for how long you should take DRYNOL.
Do not give this medicine to children under 12 years of age.
If you, or anyone else, have taken too many DRYNOL tablets, contact your doctor or pharmacist immediately.
Do not take a double dose to make up for a forgotten dose.
If you forget to take your dose on time, take it as soon as possible, and then go back to your regular dosing schedule.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Frequency not known: cannot be estimated from the available data
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the blisters after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
DRYNOL tablets are white, oval, biconvex and scored (length 10 mm, width 5 mm.
The tablets are supplied in blisters of 10, 20 , 30, 40 or 50 tablets
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Local Representative in Ireland A. Menarini Pharmaceuticals Ireland Ltd.
This medicinal product is authorised in the Member States of the EEA under the following names:
Austria: Nasitop 20 mg Tabletten
Belgium: Bellozal 20 mg Tablet
Bulgaria: Fortecal 20 mg Таблетка
Cyprus: Bilaz 20 mg Δισκίο
Czech Republic: Xados 20 mg Tablety
Denmark: Revitelle 20 mg Tablet
Finland: Revitelle 20 mg Tabletti
France: Bilaska 20 mg Comprimé
Germany: Bilaxten 20 mg Tabletten
Greece: Bilaz 20 mg Δισκίο
Hungary: Lendin 20 mg tabletta
Iceland: Bilaxten 20 mg Tafla
Ireland: Drynol 20 mg tablets
Italy: Olisir 20 mg Compressa
Latvia: Opexa 20 mg Tabletes
Lithuania: Opexa 20 mg Tabletìs
Luxembourg: Bellozal 20 mg Tablet
Malta: Gosall 20 mg tablets
Norway: Zilas 20 mg Tablett
Portugal: Lergonix 20 mg Comprimido
Romania: Borenar 20 mg Comprimate
Slovak Republic: Omarit 20 mg Tableta
Slovenia: Bilador 20 mg tablete
Spain: Ibis 20 mg Comprimido
Sweden: Bilaxten 20 mg Tablett
United Kingdom: Ilaxten 20 mg tablets